This company listing is no longer active
Spectral MD Holdings Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Spectral MD Holdings's earnings have been declining at an average annual rate of -27.4%, while the Medical Equipment industry saw earnings declining at 12.8% annually. Revenues have been growing at an average rate of 40% per year.
Información clave
-27.4%
Tasa de crecimiento de los beneficios
4.7%
Tasa de crecimiento del BPA
| Crecimiento de la industria Medical Equipment | -9.5% |
| Tasa de crecimiento de los ingresos | 40.0% |
| Rentabilidad financiera | -69.0% |
| Margen neto | -24.4% |
| Última actualización de beneficios | 31 Mar 2023 |
Actualizaciones de resultados anteriores recientes
Recent updates
Desglose de ingresos y gastos
Cómo gana y gasta dinero Spectral MD Holdings. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Mar 23 | 25 | -6 | 16 | 0 |
| 31 Dec 22 | 25 | -3 | 13 | 0 |
| 30 Sep 22 | 23 | -3 | 13 | 0 |
| 30 Jun 22 | 20 | -4 | 13 | 0 |
| 31 Mar 22 | 18 | -5 | 12 | 0 |
| 31 Dec 21 | 15 | -5 | 11 | 0 |
| 30 Sep 21 | 16 | -4 | 10 | 0 |
| 30 Jun 21 | 17 | -3 | 9 | 0 |
| 31 Mar 21 | 17 | -1 | 8 | 0 |
| 31 Dec 20 | 17 | 1 | 7 | 0 |
Ingresos de calidad: SMD is currently unprofitable.
Margen de beneficios creciente: SMD is currently unprofitable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Insufficient data to determine if SMD's year-on-year earnings growth rate was positive over the past 5 years.
Acelerando crecimiento: Unable to compare SMD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Beneficios vs. Industria: SMD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-18.3%).
Rentabilidad financiera
Alta ROE: SMD has a negative Return on Equity (-68.99%), as it is currently unprofitable.